Eyenovia

Developer of microdose therapies for treating myopia

placeNew York City, New York, United States calendar_todayFounded 2014 groups41 employees language eyenovia.com

Registered entities

Social engagement

Social engagement: 7.9K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Private Medical Equity, Eshelman Ventures, Senju Pharmaceutical; 1 has since exited.

Investor typeCountShare
Venture capital120%
Private equity240%
Angel & family office120%
Other / undisclosed120%

Recent activity

21 Jul 2025
Event
Corporate Update Event featuring CIO Hyunsu Jung and CEO Michael Rowe
Coming soon